ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation

Analyzing real-time PCR data by the comparative CT method

Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459

Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism

Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363

The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men

Yang, X., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,277

Recovery of learning and memory is associated with chromatin remodelling

Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168

Regulation of histone acetylation during memory formation in the hippocampus

Levenson, J. M., O'Riordan, K. J., Brown, K. D., Trinh, M. A., Molfese, D. L., & Sweatt, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402229200 · Cited by 1,131

The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade

Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870

Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential

Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606

Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases

Numakawa, T., Odaka, H., & Adachi, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113650 · Cited by 367

Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies

Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors—What Some May Have Forgotten or Would Rather Forget?

Shen, S., & Kozikowski, A. P. (2016) · ChemMedChem · doi:10.1002/cmdc.201500486 · Cited by 288

Sexual dimorphism in predisposition to Alzheimer's disease

Fisher, D. W., Bennett, D. A., & Dong, H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.004 · Cited by 270

Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis

Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 276

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220

Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH

Prasad, H., & Rao, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801612115 · Cited by 207

Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

Liao, F., Yoon, H., & Kim, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000383 · Cited by 191

Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review

Dinda, B., Dinda, M., Kulsi, G., Chakraborty, A., & Dinda, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.009 · Cited by 178

Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory

Li, X., Zhang, J., Li, D., He, C., He, K., Xue, T., Wan, L., Zhang, C., & Liu, Q. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.005 · Cited by 165

Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer’s disease: a meta-analysis study (N=7277)

Qin, X.-Y., Cao, C., Cawley, N. X., Liu, T.-T., Yuan, J., Loh, Y. P., & Cheng, Y. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.62 · Cited by 136

APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-κB activation

Arnaud, L., Benech, P., Greetham, L., Stephan, D., Jimenez, A., Jullien, N., García‐González, L., Tsvetkov, P. O., Devred, F., Sancho-Martinez, I., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111200 · Cited by 130

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials

Nelson, T. J., Sun, M., Lim, C. S., Sen, A., Khan, T. K., Chirila, F. V., & Alkon, D. L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170161 · Cited by 118

HDAC6 in Diseases of Cognition and of Neurons

LoPresti, P. (2020) · Cells · doi:10.3390/cells10010012 · Cited by 105

Sex differences in Alzheimer’s disease: Understanding the molecular impact

Toro, C. A., Zhang, L., Cao, J., & Cai, D. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.031 · Cited by 105

Role of histone deacetylases and their inhibitors in neurological diseases

Zhang, L.-Y., Zhang, S.-Y., Wen, R., Zhang, T.-N., & Yang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107410 · Cited by 84

Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 84

PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice

Segev, Y., Barrera, I., Ounallah-Saad, H., Wibrand, K., Sporild, I., Livne, A., Rosenberg, T., David, O., Mints, M., Bramham, C. R., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5241-14.2015 · Cited by 81

Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ25-35-induced rat model of Alzheimer’s disease

Li, H., Tan, Y., Cheng, X. M., Zhang, Z., Huang, J., Hui, S., Zhu, L., Liu, Y., Zhao, D. S., Liu, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.990307 · Cited by 77

Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders

Gupta, R. V., Ambasta, R. K., & Kumar, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117278 · Cited by 85

Epigenetic Regulation of BDNF Gene during Development and Diseases

Chen, K.-W., & Chen, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030571 · Cited by 75

Brain biometals and Alzheimer's disease – boon or bane?

Prakash, A. K., Dhaliwal, G. K., Kumar, P., & Majeed, A. B. A. (2016) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1174118 · Cited by 71

C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease

Xia, Y., Wang, Z.-H., Zhang, J., Liu, X., Yu, S. P., Ye, K. X., Wang, J., Ye, K., & Wang, X. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00956-4 · Cited by 66

Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson’s Disease

Wu, Q., Yang, X., Zhang, L., Zhang, Y., & Feng, L. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0199-2 · Cited by 66

APOEε4 impacts up-regulation of brain-derived neurotrophic factor after a six-month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study

Allard, J. S., Ntekim, O. E., Johnson, S. P., Ngwa, J. S., Bond, V., Pinder, D., Gillum, R. F., Fungwe, T. V., Kwagyan, J., & Obisesan, T. O. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.001 · Cited by 69

Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease

Theendakara, V., Peters-Libeu, C. A., Bredesen, D. E., & Rao, R. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0757-2 · Cited by 63

ApoE isoforms differentially regulates cleavage and secretion of BDNF

Sen, A., Nelson, T. J., & Alkon, D. L. (2017) · Molecular Brain · doi:10.1186/s13041-017-0301-3 · Cited by 60

Autophagy regulation by acetylation—implications for neurodegenerative diseases

Son, S. M., Park, S. J., Fernandez-Estévez, M., & Rubinsztein, D. C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00556-4 · Cited by 59

PGC-1α or FNDC5 Is Involved in Modulating the Effects of Aβ1−42 Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, Aβ Deposition and Cognitive Decline of APP/PS1 Tg Mice

Xia, D., Huang, X., Bi, C., Mao, L., Peng, L., & Qian, H. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00065 · Cited by 57

Neurotrophins and Other Growth Factors in the Pathogenesis of Alzheimer’s Disease

Numakawa, T., & Kajihara, R. (2023) · Life · doi:10.3390/life13030647 · Cited by 57

Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro

Iannucci, J., Sen, A., & Grammas, P. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43010018 · Cited by 57

Histone acetylation in neuronal (dys)function

Bonnaud, E. M., Suberbielle, E., & Malnou, C. E. (2016) · BioMolecular Concepts · doi:10.1515/bmc-2016-0002 · Cited by 58

Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer

Yang, C., Liu, Y.-P., Dai, H.-Y., Shiue, Y., Tsai, C.-J., Huang, M., & Yeh, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4749 · Cited by 53

Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target

Wu, Y., Hou, F., Wang, X., Kong, Q., Han, X., & Bai, B. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00114 · Cited by 52

Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease

Bai, P., Mondal, P., Bagdasarian, F. A., Rani, N., Liu, Y., Gomm, A., Tocci, D. R., Choi, S. H., Wey, H., Tanzi, R. E., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.017 · Cited by 50

Unlocking Alzheimer’s Disease: The Role of BDNF Signaling in Neuropathology and Treatment

Alqahtani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Alexiou, A. T., Papadakis, M., Hemeda, L. R., Faheem, S. A., & Batiha, G. E. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08857-x · Cited by 57

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s

Yang, A., Kantor, B., & Chiba‐Falek, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031244 · Cited by 51

Ginsenoside Reduces Cognitive Impairment During Chronic Cerebral Hypoperfusion Through Brain-Derived Neurotrophic Factor Regulated by Epigenetic Modulation

Wan, Q., Ma, X., Zhang, Z., Sun, T., Feng, X., Zhao, G., & Wu, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9868-4 · Cited by 50

Donepezil attenuates vascular dementia in rats through increasing BDNF induced by reducing HDAC6 nuclear translocation

Jian, W., Zhang, Z., Zhan, J.-H., Chu, S., Ye, P., Zhao, M., Wang, Q., & Chen, N. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0334-5 · Cited by 51

Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis

Braschi, C., Capsoni, S., Narducci, R., Poli, A., Sansevero, G., Brandi, R., Maffei, L., Cattaneo, A., & Berardi, N. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01646-5 · Cited by 53

OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice

Yuan, C., Guo, X., Zhou, Q., Du, F., Jiang, W., Zhou, X., Liu, P., Chi, T., Ji, X., Gao, J., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.028 · Cited by 49

ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer’s disease

Wang, Z.-H., Xia, Y., Liu, P., Liu, X., Edgington‐Mitchell, L. E., Lei, K., Yu, S. P., Wang, X., & Ye, K. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102032 · Cited by 48

Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer’s disease pathology in a mouse model

Wang, Z.-H., Xia, Y., Wu, Z., Kang, S. S., Zhang, J.-C., Liu, P., Liu, X., Song, W., Huin, V., Dhaenens, C., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102212 · Cited by 48

p38/Sp1/Sp4/HDAC4/BDNF Axis Is a Novel Molecular Pathway of the Neurotoxic Effect of the Methylmercury

Guida, N., Laudati, G., Mascolo, L., Valsecchi, V., Sirabella, R., Selleri, C., Renzo, G. D., Canzoniero, L. M. T., & Formisano, L. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00008 · Cited by 47

Protein Kinase Cϵ (PKCϵ) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95

Sen, A., Hongpaisan, J., Wang, D., Nelson, T. J., & Alkon, D. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730440 · Cited by 46

Inter-relationship of Histone Deacetylase-6 with Tau-cytoskeletal organization and remodeling

Balmik, A. A., & Chinnathambi, S. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151202 · Cited by 44

PSD-95-nNOS Coupling Regulates Contextual Fear Extinction in the Dorsal CA3

Cai, C.-Y., Chen, C., Zhou, Y., Han, Z., Qin, C., Cao, B., Tao, Y., Bian, X.-L., Lin, Y., Chang, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30899-4 · Cited by 41

Exposure to fluoride aggravates the impairment in learning and memory and neuropathological lesions in mice carrying the APP/PS1 double-transgenic mutation

Cao, K., Xiang, J., Dong, Y., Xu, Y., Li, Y., Song, H., Zeng, X.-X., Ran, L., Hong, W., & Guan, Z.-Z. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0490-3 · Cited by 40

Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review

Tokgöz, S., & Claassen, J. A. H. R. (2021) · Cardiology and Therapy · doi:10.1007/s40119-020-00209-z · Cited by 42

Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer’s Disease Hippocampus1

Sen, A., Nelson, T. J., Alkon, D. L., & Hongpaisan, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171008 · Cited by 40

BDNF/proBDNF Interplay in the Mediation of Neuronal Apoptotic Mechanisms in Neurodegenerative Diseases

Mitrović, M. M., Selaković, D., Jovicic, N. U., Ljujić, B., & Rosic, G. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104926 · Cited by 42

The mi R ‐203/ SNAI 2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK ‐3β/β‐ CATENIN signal pathway

Tian, X., Tao, F., Zhang, B., Dong, J., & Zhang, Z. (2018) · IUBMB Life · doi:10.1002/iub.1720 · Cited by 37

ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis

Lemarchant, S., Pomeshchik, Y., Kidin, I., Kärkkäinen, V., Valonen, P. K., Lehtonen, Š., Goldsteins, G., Malm, T., Kanninen, K. M., & Koıstınaho, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0078-3 · Cited by 39

An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer’s Disease

Numakawa, T., & Kajihara, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031596 · Cited by 35

Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease

Chen, Y., Lu, C.-H., Ke, C., Chiu, S.-J., Chang, C., Yang, B., Gelovani, J. G., & Liu, R.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168633 · Cited by 33

Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle

Mattson, M. P. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.3 · Cited by 34

The X Files: “The Mystery of X Chromosome Instability in Alzheimer’s Disease”

Bajić, V., Essack, M., Živković, L., Stewart, A. J., Zafirovic, S. S., Bajić, V. B., Gojobori, T., Isenović, E. R., & Spremo‐Potparević, B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01368 · Cited by 33

APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes

Giarratana, A. O., Zheng, C., Reddi, S., Teng, S. L., Berger, D. S., Adler, D., Sullivan, P. M., Thakker‐Varia, S., & Alder, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76849-x · Cited by 39

Status of precision medicine approaches to traumatic brain injury

Reddi, S., Thakker‐Varia, S., Alder, J., & Giarratana, A. O. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335824 · Cited by 33

Synaptically Localized Transcriptional Regulators in Memory Formation

Uchida, S., & Shumyatsky, G. P. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.023 · Cited by 33

Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease

Kantor, B., O’Donovan, B., & Chiba‐Falek, O. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102635 · Cited by 38

Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo

Schlüter, A., Aksan, B., Fioravanti, R., Valente, S., Mai, A., & Mauceri, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01658-x · Cited by 31

MC1568 Inhibits Thimerosal-Induced Apoptotic Cell Death by Preventing HDAC4 Up-Regulation in Neuronal Cells and in Rat Prefrontal Cortex

Guida, N., Laudati, G., Mascolo, L., Cuomo, O., Anzilotti, S., Sirabella, R., Santopaolo, M., Galgani, M., Montuori, P., Renzo, G. D., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw157 · Cited by 30

Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation

Kakoty, V., Sarathlal, K. C., Kumari, S., Yang, C., Dubey, S. K., Sahebkar, A., Kesharwani, P., & Taliyan, R. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01187-z · Cited by 30

MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma

Wang, Y., Xia, Y., Hu, K., Zeng, M., Zhi, C., Lai, M., Wu, L., Liu, S., Zeng, S., Huang, Z., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32321 · Cited by 29

Neuro-regeneration Therapeutic for Alzheimer’s Dementia: Perspectives on Neurotrophic Activity

Sun, M., & Alkon, D. L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.008 · Cited by 31

Epigenetic enzymes: A role in aging and prospects for pharmacological targeting

PASYUKOVA, E. G., Symonenko, A. V., Rybina, O. Y., & Vaiserman, A. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101312 · Cited by 28

The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease

Cissé, M., Duplan, E., & Checler, F. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00229 · Cited by 28

Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment

Čechová, K., Andel, R., Angelucci, F., Chmátalová, Z., Marková, H., Laczó, J., Vyhnálek, M., Maťoška, V., Kaplan, V., Nedelská, Z., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190464 · Cited by 28

Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease

Winick‐Ng, W., & Rylett, R. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00060 · Cited by 28

Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis

More, S., Bonnereau, J., Wouters, D., Spotbeen, X., Karras, P., Rizzollo, F., Killian, T., Venken, T., Naulaerts, S., Vervoort, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp6164 · Cited by 25

LRP1 receptor-mediated immunosuppression of α-MMC on monocytes

Deng, N., Li, M., Shen, D., He, Q., Sun, W., Liu, M., Liu, Y., Zhou, Y., Zheng, J., & Shen, F. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.036 · Cited by 25

Peptides Derived from Growth Factors to Treat Alzheimer’s Disease

Gascon, S., Jann, J., Langlois-Blais, C., Plourde, M., Lavoie, C. L., & Faucheux, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116071 · Cited by 24

HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen‐glucose deprivation injuries via H3K14 and H4K5 acetylation‐mediated BDNF expression

Fang, Y., Chan, L., Liou, J., Tu, Y., Lai, M.-J., Chen, C. Y., Vidyanti, A. N., Lee, H., & Hu, C. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15358 · Cited by 22

Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activation

Wang, L., Shen, F., Zhang, M., He, Q., Zhao, H., Yu, X., Yang, S., Liu, Y., Deng, N., Zheng, J., et al. (2016) · Toxicology · doi:10.1016/j.tox.2016.05.025 · Cited by 22

3,4-Dihydroxyphenylethanol Assuages Cognitive Impulsivity in Alzheimer’s Disease by Attuning HPA-Axis via Differential Crosstalk of α7 nAChR with MicroRNA-124 and HDAC6

MohanaSundaram, A., Shanmugarajan, T. S., & Ravichandiran, V. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00532 · Cited by 22

Dexmedetomidine attenuates the toxicity of β‑amyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5

Wang, Y., Jia, A., & Ma, W. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9694 · Cited by 22

Distinct Expression Pattern of Epigenetic Machinery Genes in Blood Leucocytes and Brain Cortex of Depressive Patients

Rey, R., Chauvet‐Gélinier, J., Suaud‐Chagny, M., Ragot, S., Bonin, B., d’Amato, T., & Teyssier, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1406-0 · Cited by 21

Epigenetic Regulation in Ischemic Neuroprotection: The Dual Role of HDACs and HATs in Neuroinflammation and Recovery

Lisek, M., Bochenska, N., Tomczak, J., Duraj, J., & Boczek, T. (2025) · Antioxidants · doi:10.3390/antiox14081015 · Cited by 19

Cytoplasmic HDAC4 recovers synaptic function in the 3×Tg mouse model of Alzheimer's disease

Colussi, C., Aceto, G., Ripoli, C., Bertozzi, A., Puma, D. D. L., Paccosi, E., D’Ascenzo, M., & Grassi, C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12861 · Cited by 19

Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy

Turkman, N., Liu, D., & Pirola, I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114011 · Cited by 18

Histone Deacetylase Inhibitor Improves the Dysfunction of Hippocampal Gamma Oscillations and Fast Spiking Interneurons in Alzheimer’s Disease Model Mice

Takasu, K., Niidome, K., Hasegawa, M., & Ogawa, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.782206 · Cited by 18

APOE–NOTCH axis governs elastogenesis during human cardiac valve remodeling

Liu, Z., Liu, Y., Yu, Z., Tan, C., Pek, N. M. Q., O’Donnell, A., Wu, A., Glass, I. A., Winlaw, D. S., Guo, M., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00510-3 · Cited by 18

Procyanidins Extracted from Lotus Seedpod Ameliorate Amyloid‐β‐Induced Toxicity in Rat Pheochromocytoma Cells

Huang, H., Yan, P., Sun, T., Mo, X., Yin, J., Li, P., Zhu, Y., Rong, S., Yang, W. Q., Chen, X., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4572893 · Cited by 17

Dysregulation of the SNARE-binding protein Munc18-1 impairs BDNF secretion and synaptic neurotransmission: a novel interventional target to protect the aging brain

Lee, Y. I., Kim, Y. G., Pyeon, H., Ahn, J., Logan, S., Orock, A. M., Joo, K. M., Lőrincz, A., & Deák, F. (2019) · GeroScience · doi:10.1007/s11357-019-00067-1 · Cited by 17

Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?

Jiao, F., Jiang, D., Li, Y., Mei, J., Wang, Q., & Li, X. (2022) · Cells · doi:10.3390/cells11203201 · Cited by 16

Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease

Charou, D., Rogdakis, T., Latorrata, A., Valcárcel, M., Papadogiannis, V., Athanasiou, C., Tsengenes, A., Papadopoulou, M. A., Lypitkas, D., Lavigne, M. D., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03818-w · Cited by 18

Machine learning-guided fabrication of carbon dot–pepsin nano-conjugates for enhanced bioimaging, synergistic drug delivery, and visible light-induced photosensitization

Banerjee, S., Mandal, S., Singh, S., Sen, A., & Das, P. (2025) · Nanoscale · doi:10.1039/d5nr00752f · Cited by 14

A novel insight into neurological disorders through HDAC6 protein–protein interactions

Sangani, N. B., Koetsier, J., Mélius, J., Kutmon, M., Ehrhart, F., Evelo, C. T., Curfs, L., Reutelingsperger, C. P. M., & Eijssen, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-65094-1 · Cited by 14

HIV Promotes Neurocognitive Impairment by Damaging the Hippocampal Microvessels

Sharma, A. L., Wang, H., Zhang, Z., Millien, G., Tyagi, M., & Hongpaisan, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02890-8 · Cited by 12

S-nitrosoglutathione modulates HDAC2 and BDNF levels in the brain and improves cognitive deficits in experimental model of Alzheimer’s disease in rats

Dubey, H., Dubey, A., Gulati, K., & Ray, A. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2150190 · Cited by 12

Targeting epigenetic mechanisms in amyloid-β–mediated Alzheimer’s pathophysiology: unveiling therapeutic potential

Li, J. Z., Ramalingam, N., & Li, S. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01827 · Cited by 11

Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 14

BDNF Val66Met Polymorphism and Gamma Band Disruption in Resting State Brain Functional Connectivity: A Magnetoencephalography Study in Cognitively Intact Older Females

Rodríguez‐Rojo, I. C., Cuesta, P., López, M. E., de Frutos‐Lucas, J., Bruña, R., Pereda, E., Barabash, A., Carrasco, P. M., Montenegro-Peña, M., Marcos, A., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00684 · Cited by 11

Effect of BDNF Val66Met on hippocampal subfields volumes and compensatory interaction with APOE-ε4 in middle-age cognitively unimpaired individuals from the ALFA study

Vilor‐Tejedor, N., Operto, G., Evans, T. E., Falcón, C., Crous‐Bou, M., Minguillón, C., Cacciaglia, R., Milà‐Alomà, M., Grau‐Rivera, O., Suárez‐Calvet, M., et al. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02125-3 · Cited by 9

Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility

Chuang, H.-H., Huang, M., Wang, P., Liu, Y., Hsiao, M., & Yang, C. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.27426 · Cited by 9

Using a murine model to explore the impact of sex and APOE4 on cisplatin-induced cognitive impairment

Fowler, C. G., Tarantino, M. I., Gillett, A. E., Muñiz, V., Anderson, M. A., Bonner, R. L., & Vichaya, E. G. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.05.010 · Cited by 8

Amyloid β Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer's Associated Heart Disease

Elia, A., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Carey, A. M., Zhao, H., Javadov, S. A., & Fossati, S. (2026) · Advanced Science · doi:10.1002/advs.202511924 · Cited by 9

ApoE isoforms differentially regulates cleavage and secretion of BDNF

Sen, A., Nelson, T. J., & Alkon, D. L. (2017) · Molecular Brain · doi:10.1186/s13041-017-0301-3 · Cited by 60

P3–209: ApoE4 induces Aβ mediated apoptosis in vivo

Belinson, H., & Michaelson, D. M. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1478

PGC-1α or FNDC5 Is Involved in Modulating the Effects of Aβ1−42 Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, Aβ Deposition and Cognitive Decline of APP/PS1 Tg Mice

Xia, D., Huang, X., Bi, C., Mao, L., Peng, L., & Qian, H. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00065 · Cited by 57

O2‐02‐02: Novel Transcriptional Role of APOE4

Theendakara, V. P., Peters-Libeu, C. A., Bredesen, D. E., & Rao, R. V. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.400 · Cited by 2

PL‐03‐03: Apolipoprotein E4: The most prevalent yet understudied genetic risk factor of Alzheimer's disease

Michaelson, D. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.369 · Cited by 1